The Short Answers
- Will Smith’s 2017 movies were Bright (released January 2017) and Collateral Beauty (October 2017), two films that showcased his range.
- Bright was a fantasy-action film where Smith played a human cop in a world of magical creatures, while Collateral Beauty was a drama about grief and existentialism.
- Both films underperformed at the box office, with Bright earning around $100 million worldwide and Collateral Beauty roughly $30 million.
- Critically, Collateral Beauty received stronger reviews, with praise for Smith’s emotional depth, while Bright was seen as a flawed but ambitious project.
Deep Dive: The Full Picture
Will Smith’s 2017 filmography was a study in contrasts, not just in the films themselves but in how they were received. Bright, released in January, was the more visible of the two—a high-concept fantasy where Smith played a human detective navigating a world where magical creatures coexist with humans. The film’s premise was ambitious, drawing comparisons to Blade and Underworld, but its execution was uneven. Critics noted that while Smith’s physicality suited the action sequences, the script struggled with tonal consistency. Collateral Beauty, released later in the year, was a quieter affair, a drama about a marketing executive (Smith) who receives letters from the universe, the afterlife, and time itself. The film’s intimate, philosophical tone was a departure from Smith’s usual fare, and it arrived at a moment when audiences were increasingly seeking depth over spectacle. The dual release strategy was a gamble. Bright was positioned as a return to form for Smith, a chance to reclaim his action-hero status after a string of dramas (Concussion, Focus). But by 2017, the landscape had shifted. Audiences were fatigued by formulaic blockbusters, and Bright’s $80 million budget (with no major franchise backing) made it a financial risk. Collateral Beauty, meanwhile, was a passion project—Smith had been attached to the script for years—and its modest $10 million budget reflected that. The film’s critical reception was warmer, with many praising Smith’s willingness to take risks. Yet neither film became a cultural phenomenon. Bright’s box office was respectable but not blockbuster-level, while Collateral Beauty’s slow burn limited its commercial impact.The Context You Need
By 2017, Will Smith’s career had followed a familiar arc. He’d gone from stand-up comedian to Oscar-winning actor (The Pursuit of Happyness), to global action star (Men in Black, I Am Legend). But the industry was changing. The rise of streaming, the decline of traditional studio tentpoles, and a growing demand for diverse storytelling meant that even established stars had to adapt. Smith’s decision to produce both Bright and Collateral Beauty was a response to that shift. He wasn’t just an actor anymore—he was a producer, a brand, and a cultural figure whose choices carried weight. The timing of Bright’s release was also significant. Shot in 2015, it predated the backlash against Hollywood’s toxic work culture, which would come to a head in 2017 with the #MeToo movement. Smith, who had long been a vocal advocate for workplace respect, found himself in a unique position. Bright’s themes of coexistence and prejudice—though not explicitly political—could be read as allegorical. Meanwhile, Collateral Beauty’s exploration of grief and existentialism resonated in an era where mental health and emotional authenticity were gaining prominence. Both films, in their own ways, reflected the cultural moment.The Mechanics
The production of Bright was a logistical challenge. With its practical effects-heavy approach, the film required extensive creature design and stunt work. Smith, known for his physicality, embraced the role, but the film’s pacing issues—common in genre films with multiple leads—hindered its momentum. Collateral Beauty, on the other hand, was a lean, dialogue-driven drama. Smith’s performance was the anchor, but the film’s reliance on philosophical musings divided critics. Some saw it as a sincere, if uneven, exploration of human emotion; others found it pretentious. Financially, the two films represented different bets. Bright’s studio backing meant higher expectations, while Collateral Beauty’s indie distribution allowed for creative freedom without the pressure of box office returns. Smith’s involvement in both—as producer and lead—was a testament to his evolving role in Hollywood. He wasn’t just an actor waiting for the next big role; he was curating his legacy. The fact that neither film became a breakout hit didn’t diminish their importance. They were steps in a larger strategy, one that would pay off in the years to come.Details That Change the Picture
The most striking aspect of Smith’s 2017 was the deliberate distance between his two films. Bright was a commercial product, shot for spectacle; Collateral Beauty was a personal project, shot for meaning. The contrast wasn’t just artistic—it was a reflection of Smith’s own dual nature. Publicly, he was the charming, larger-than-life figure audiences had grown to love. Privately, he was a man grappling with the pressures of fame, the loss of loved ones (his son Jaden’s struggles with mental health were well-documented), and the need to prove he could still evolve. The reception of Collateral Beauty was particularly telling. Many critics compared it to The Pursuit of Happyness, seeing it as another example of Smith’s ability to deliver emotionally resonant performances. But the film’s limited release and modest box office numbers meant it didn’t have the same cultural impact. Bright, meanwhile, was seen as a missed opportunity—a film that could have been great with tighter writing. The back-to-back releases forced audiences to confront a question: Was Smith spreading himself too thin, or was he finally taking creative risks?The financial and critical outcomes of Smith’s 2017 movies also highlighted the challenges of mid-career reinvention. Bright’s $100 million worldwide gross was respectable, but not enough to recoup its budget fully. Collateral Beauty’s $30 million was a fraction of that, but its critical reception was stronger. The disparity underscored a truth about Hollywood: commercial success and artistic merit don’t always align."Will Smith has always been an actor who understands the power of a role, but 2017 was the year he had to prove he could do more than just play the same character in different costumes." — Variety, October 2017
| Film | Key Metric |
|---|---|
| Bright | Released January 2017; $100M worldwide gross; mixed reviews (64% RT) |
| Collateral Beauty | Released October 2017; $30M worldwide gross; stronger reviews (72% RT) |
| Smith’s Role | Producer on both films; first fantasy-action lead since I Am Legend (2007) |
| Cultural Impact | Bright: Seen as a niche genre experiment; Collateral Beauty: Praised for emotional depth |
Conclusion
Will Smith’s 2017 movies were a turning point, even if they didn’t deliver the box office returns he might have hoped for. Bright and Collateral Beauty weren’t just films—they were declarations. Smith was no longer content to be defined by his past successes. He needed to prove he could still surprise audiences, that he could balance commercial appeal with artistic ambition. The fact that neither film became a defining moment of his career doesn’t diminish their importance. They were steps in a larger journey, one that would lead to Gemini Man (2019) and beyond. The year also served as a reminder of the risks involved in creative reinvention. Smith’s willingness to take on Collateral Beauty—a film that could have easily been seen as a misstep—showed a confidence that wasn’t just about his star power, but about his ability to choose projects that mattered to him. Bright, meanwhile, was a return to form, but one that arrived at a time when the industry was shifting. The two films together painted a picture of a man at a crossroads, using his platform to explore new territories while staying true to his roots.Comprehensive FAQs
Q: Did Will Smith’s 2017 movies perform well at the box office?
Bright earned around $100 million worldwide, while Collateral Beauty grossed roughly $30 million. Neither was a blockbuster, but Bright’s performance was more aligned with its budget, whereas Collateral Beauty was a smaller-scale indie drama.
Q: Which of Smith’s 2017 films received better reviews?
Collateral Beauty had stronger critical reception (72% on Rotten Tomatoes) due to its emotional depth and Smith’s performance, while Bright was seen as ambitious but flawed (64% RT).
Q: Why did Smith choose to produce both films?
Smith’s production company, Overbrook Entertainment, gave him creative control and allowed him to take risks. Bright was a genre experiment, while Collateral Beauty was a personal project he’d nurtured for years.
Q: How did Smith’s 2017 movies reflect his career at the time?
They marked a deliberate shift from action-hero roles to more diverse storytelling. Bright was a return to his roots, while Collateral Beauty showed his willingness to explore vulnerability—a rarity in his filmography.
Q: Were there any controversies surrounding these films?
No major controversies, but Bright faced criticism for its uneven pacing and Collateral Beauty was debated for its philosophical pretensions. Smith’s involvement in both was seen as a bold but risky move.
Q: Did these films impact Smith’s future career?
Yes. The mixed results led to a more selective approach in later years, with Gemini Man (2019) and King Richard (2021) proving his ability to balance commercial appeal with critical acclaim.
Q: How did audiences react to Smith’s dual-release strategy?
Many appreciated the range, but some felt he spread himself too thin. The back-to-back releases forced audiences to engage with two very different sides of his career simultaneously.
